Detalhe da pesquisa
1.
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity.
Hematol Oncol
; 38(4): 478-486, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32542788
2.
From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights.
Int J Mol Sci
; 20(19)2019 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590328
3.
Clinical trials of bisphosphonates in multiple myeloma.
Clin Adv Hematol Oncol
; 10(9): 582-7, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23073123
4.
The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future.
Oncologist
; 16(5): 651-62, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21493759
5.
Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.
Leuk Lymphoma
; 48(1): 56-64, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17325848
6.
Bisphosphonates-associated osteonecrosis of the jaw: A long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over time.
Am J Hematol
; 84(12): 850-2, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19862827
7.
High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.
Clin Cancer Res
; 15(18): 5829-39, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19737962